» Articles » PMID: 31090156

The Impact of Variations in Transcription of DICER and AGO2 on Exacerbation of Childhood B-cell Lineage Acute Lymphoblastic Leukaemia

Overview
Publisher Wiley
Specialty Pathology
Date 2019 May 16
PMID 31090156
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of microRNA in eukaryotic cells is subject to tightly regulated processing. The altered expression of microRNAs in a number of cancers suggests their contribution to disease pathogenesis, where processing pathways may be involved in disease pathogenesis. In the present study, we evaluated changes in the profile of two main components of microRNA biogenesis, AGO2 and DICER, and assessed their correlation with disease progression in childhood acute lymphoblastic leukaemia (ALL). To achieve this aim, 25 patients afflicted with ALL were included in the study along with 25 healthy subjects as control. The expression level of AGO2 and DICER was evaluated by real-time PCR. The results revealed an increase in the expression of DICER and a decrease in AGO2 in patients. The correlation between the alteration levels of these genes with pathologic events was also studied. This increase or decrease proved to be directly correlated with the progression of the disease particularly in L1 to L2. According to the obtained results, it can be deduced that dysregulation in transcription of DICER and AGO2, involved in the formation of mature microRNAs in cytoplasm of ALL cancer cells, is a part of the pathological molecular mechanism implicated in the exacerbation of this malignancy. Therefore, the genes involved in microRNAs biogenesis that have been studied here could be considered as candidate prognostic markers especially in childhood ALL which will help towards a better understanding of the molecular basis of ALL.

Citing Articles

Plasma-based transcriptomic non-coding signature for predicting relapse in pediatric acute lymphoblastic leukemia.

Wang Y, Ma X, Li H, Zhao J, Kang M, Rong L Heliyon. 2025; 10(24):e41102.

PMID: 39759366 PMC: 11700237. DOI: 10.1016/j.heliyon.2024.e41102.


MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools.

Kyriakidis I, Kyriakidis K, Tsezou A Cancers (Basel). 2022; 14(16).

PMID: 36010971 PMC: 9406077. DOI: 10.3390/cancers14163976.


Argonaute Proteins Take Center Stage in Cancers.

Nowak I, Sarshad A Cancers (Basel). 2021; 13(4).

PMID: 33668654 PMC: 7918559. DOI: 10.3390/cancers13040788.


Dicing the Disease with Dicer: The Implications of Dicer Ribonuclease in Human Pathologies.

Theotoki E, Pantazopoulou V, Georgiou S, Kakoulidis P, Filippa V, Stravopodis D Int J Mol Sci. 2020; 21(19).

PMID: 33007856 PMC: 7583940. DOI: 10.3390/ijms21197223.


From the Argonauts Mythological Sailors to the Argonautes RNA-Silencing Navigators: Their Emerging Roles in Human-Cell Pathologies.

Pantazopoulou V, Georgiou S, Kakoulidis P, Giannakopoulou S, Tseleni S, Stravopodis D Int J Mol Sci. 2020; 21(11).

PMID: 32503341 PMC: 7312461. DOI: 10.3390/ijms21114007.


References
1.
Stanulla M, Schrappe M . Treatment of childhood acute lymphoblastic leukemia. Semin Hematol. 2008; 46(1):52-63. DOI: 10.1053/j.seminhematol.2008.09.007. View

2.
Merritt W, Lin Y, Han L, Kamat A, Spannuth W, Schmandt R . Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med. 2008; 359(25):2641-50. PMC: 2710981. DOI: 10.1056/NEJMoa0803785. View

3.
Kasinski A, Slack F . Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011; 11(12):849-64. PMC: 4314215. DOI: 10.1038/nrc3166. View

4.
Rybak A, Fuchs H, Hadian K, Smirnova L, Wulczyn E, Michel G . The let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2. Nat Cell Biol. 2009; 11(12):1411-20. DOI: 10.1038/ncb1987. View

5.
Pampalakis G, Diamandis E, Katsaros D, Sotiropoulou G . Down-regulation of dicer expression in ovarian cancer tissues. Clin Biochem. 2009; 43(3):324-7. DOI: 10.1016/j.clinbiochem.2009.09.014. View